Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Institut Curie’s RACER team in Paris advances preclinical modeling for rare cancers, focusing on sarcomas and cancers of unknown primary using cell lines, organoids, and PDX. You will work under Dr. Sarah Watson and collaborate with core facilities at Institut Curie.
The role covers establishing models from patient material, developing 3D culture systems, and performing molecular analyses to support target validation and drug screening in a biosafety 2 environment.
Laboratory
The RACER (Rare Cancers Exploration and Research) team, led by Dr. Sarah Watson within the Chemical Biology of Cancers Unit (INSERM U1339, CNRS UMR366), conducts translational research focused on rare cancers, particularly cancers of unknown primary (CUP) and soft tissue sarcomas. The team integrates genomic and transcriptomic approaches, including single-cell analyses, with innovative preclinical models and direct access to patient cohorts and biological samples from Institut Curie.
This position aims to support and expand the team's preclinical modeling activities, including cell lines, 3D cultures, organoids, and PDX. These models are central to therapeutic target validation and drug screening projects in sarcoma research. The successful candidate will work under the direct supervision of Dr. Watson and interact closely with researchers and technological platforms at Institut Curie.
Work in a Biosafety Level 2 (BSL-2) laboratory handling human samples
Occasional schedule flexibility required to accommodate cell culture experiments, in vivo studies, and receipt of clinical specimens.